Totally agree that the uptake will gather pace rapidly as this becomes mainstream technology in the global breast screening market. VHT have made massive progress and the plethora of upcoming conferences will have players clambering for this much needed technology and for a medtech company to be generating revenue at such an early stage is testament for VHT's offering.
Ann: Appendix 4C - quarterly, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
